<ul>
	<li><strong>MAO inhibitors</strong>: Sometimes serious fatal reactions have been reported with concomitant use.</li>
	<li><strong>Antidepressants</strong>: There have been greater than two fold increases of previously stable plasma levels of other antidepressants.</li>
	<li><strong>Lithium</strong>: There have been reports of increased or decreased lithium levels when used concomitantly with Fluoxetine.</li>
	<li><strong>Antipsychotics</strong>: Elevation of blood levels of haloperidol and clozapine has been observed in patients receiving concomitant Fluoxetine.</li>
	<li><strong>Anticonvulsants</strong>: Patients on stable dose of phenytoin and carbamazepine have developed elevated plasma anticonvulsant concentrations and clinical anticonvulsant toxicity following initiation of concomitant fluoxetine treatment.</li>
	<li><strong>CNS active drugs</strong>: Caution is advised if concomitant administration of Fluoxetine is required.</li>
</ul>